{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T20:50:57Z","timestamp":1761252657344},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T00:00:00Z","timestamp":1283385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s00198-010-1377-0","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T19:35:52Z","timestamp":1283369752000},"page":"1695-1701","source":"Crossref","is-referenced-by-count":23,"title":["Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients"],"prefix":"10.1007","volume":"22","author":[{"given":"A.","family":"Nakashima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. R.","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Takasugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Yorioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,2]]},"reference":[{"key":"1377_CR1","doi-asserted-by":"crossref","first-page":"S267","DOI":"10.1681\/ASN.2006080925","volume":"17","author":"JB Cannata-And\u00eda","year":"2006","unstructured":"Cannata-And\u00eda JB, Rodr\u00edguez-Garc\u00eda M, Carrillo-L\u00f3pez N, Naves-D\u00edaz M, D\u00edaz-L\u00f3pez B (2006) Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol 17:S267\u2013S273","journal-title":"J Am Soc Nephrol"},{"key":"1377_CR2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/01.ATV.18.4.535","volume":"18","author":"J Blacher","year":"1998","unstructured":"Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM (1998) Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 18:535\u2013541","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1377_CR3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1081\/CEH-200031982","volume":"26","author":"GM London","year":"2004","unstructured":"London GM, Marchais SJ, Guerin AP, Pannier B (2004) Arterial stiffness: pathophysiology and clinical impact. Clin Exp Hypertens 26:689\u2013699","journal-title":"Clin Exp Hypertens"},{"key":"1377_CR4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309\u2013319","journal-title":"Cell"},{"key":"1377_CR5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165\u2013176","journal-title":"Cell"},{"key":"1377_CR6","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","volume":"12","author":"N Bucay","year":"1998","unstructured":"Bucay N, Sarosi I, Dunstan CR et al (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260\u20131268","journal-title":"Genes Dev"},{"key":"1377_CR7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.192.4.463","volume":"192","author":"H Min","year":"2000","unstructured":"Min H, Morony S, Sarosi I et al (2000) Osteoprotegerin reverses osteoporosis by inhibiting endosteasl osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med 192:463\u2013474","journal-title":"J Exp Med"},{"key":"1377_CR8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/ajkd.2002.31402","volume":"39","author":"JJ Kazama","year":"2002","unstructured":"Kazama JJ, Shigematsu T, Yano K et al (2002) Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. Am J Kidney Dis 39:525\u2013532","journal-title":"Am J Kidney Dis"},{"key":"1377_CR9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0272-6386(03)00655-3","volume":"42","author":"K Nitta","year":"2003","unstructured":"Nitta K, Akiba T, Uchida K et al (2003) The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis 42:303\u2013309","journal-title":"Am J Kidney Dis"},{"key":"1377_CR10","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1523-1755.2005.00239.x","volume":"67","author":"DV Barreto","year":"2005","unstructured":"Barreto DV, Barreto FC, Carvalho AB et al (2005) Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors. Kidney Int 67:1576\u20131582","journal-title":"Kidney Int"},{"key":"1377_CR11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1681\/ASN.2005030260","volume":"17","author":"M Morena","year":"2006","unstructured":"Morena M, Terrier N, Jaussent I et al (2006) Plasma osteoprotegerin is associated with mortality in hemodialysis patients. J Am Soc Nephrol 17:262\u2013270","journal-title":"J Am Soc Nephrol"},{"key":"1377_CR12","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1093\/ndt\/gfn242","volume":"23","author":"G Speer","year":"2008","unstructured":"Speer G, Fekete BC, El Hadj Othmane T et al (2008) Serum osteoprotegerin level, carotid-femoral pulse wave velocity and cardiovascular survival in haemodialysis patients. Nephrol Dial Transplant 23:3256\u20133262","journal-title":"Nephrol Dial Transplant"},{"key":"1377_CR13","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.2215\/CJN.04320709","volume":"4","author":"S Nakamura","year":"2009","unstructured":"Nakamura S, Ishibashi-Ueda H, Niizuma S, Yoshihara F, Horio T, Kawano Y (2009) Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol 4:1892\u20131900","journal-title":"Clin J Am Soc Nephrol"},{"key":"1377_CR14","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1097\/01.ASN.0000100127.54107.57","volume":"14","author":"DA Coodkin","year":"2003","unstructured":"Coodkin DA, Bragg-Gresham JL, Koenig KG et al (2003) Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The dialysis outcomes and practice patterns study (DOPPS). J Am Soc Nephrol 14:3270\u20133277","journal-title":"J Am Soc Nephrol"},{"key":"1377_CR15","first-page":"774","volume":"22","author":"K Matsubara","year":"2009","unstructured":"Matsubara K, Stenvinkel P, Qureshi AR et al (2009) Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease. J Nephrol 22:774\u2013782","journal-title":"J Nephrol"},{"key":"1377_CR16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2215\/CJN.02280508","volume":"4","author":"H Honda","year":"2009","unstructured":"Honda H, Ueda M, Kojima S et al (2009) Assessment of myeloperoxidase and oxidative alpha1-antitrypsin in patients on hemodialysis. Clin J Am Soc Nephrol 4:142\u2013151","journal-title":"Clin J Am Soc Nephrol"},{"key":"1377_CR17","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1210\/jc.2003-030088","volume":"88","author":"M Misra","year":"2003","unstructured":"Misra M, Soyka LA, Miller KK et al (2003) Serum osteoprotegerin in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 88:3816\u20133832","journal-title":"J Clin Endocrinol Metab"},{"key":"1377_CR18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5414\/CNP64064","volume":"64","author":"JJ Kazama","year":"2005","unstructured":"Kazama JJ, Omori K, Takahashi N et al (2005) Maxacalcitol therapy decreases circulating osteoprotegerin levels in dialysis patients with secondary hyperparathyroidism. Clin Nephrol 64:64\u201368","journal-title":"Clin Nephrol"},{"key":"1377_CR19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.4.5893.643","volume":"4","author":"RB Payne","year":"1973","unstructured":"Payne RB, Little AJ, Williams RB, Milner JR (1973) Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J 4:643\u2013646","journal-title":"Br Med J"},{"key":"1377_CR20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"key":"1377_CR21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1291\/hypres.25.359","volume":"25","author":"A Yamashina","year":"2002","unstructured":"Yamashina A, Tomiyama H, Takeda K et al (2002) Validity, reproducibility, and clinical significance of noninvasive brachial\u2013ankle pulse wave velocity measurement. Hypertens Res 25:359\u2013364","journal-title":"Hypertens Res"},{"key":"1377_CR22","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.2337\/diacare.24.12.2107","volume":"24","author":"E Suzuki","year":"2001","unstructured":"Suzuki E, Kashiwagi A, Nishio Y et al (2001) Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patients. Diab Care 24:2107\u20132114","journal-title":"Diab Care"},{"key":"1377_CR23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0169-2607(97)00043-6","volume":"54","author":"H Heinzl","year":"1997","unstructured":"Heinzl H, Kaider A (1997) Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed 54:201\u2013208","journal-title":"Comput Methods Programs Biomed"},{"key":"1377_CR24","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1093\/ndt\/gfp253","volume":"24","author":"MK Sigrist","year":"2009","unstructured":"Sigrist MK, Levin A, Er L, McIntyre CW (2009) Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease. Nephrol Dial Transplant 24:3157\u20133162","journal-title":"Nephrol Dial Transplant"},{"key":"1377_CR25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1515\/CCLM.2009.075","volume":"47","author":"M Mesquita","year":"2009","unstructured":"Mesquita M, Demulder A, Damry N et al (2009) Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease. Clin Chem Lab Med 47:339\u2013346","journal-title":"Clin Chem Lab Med"},{"key":"1377_CR26","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.2215\/CJN.02720409","volume":"4","author":"JJ Carrero","year":"2009","unstructured":"Carrero JJ, Stenvinkel P (2009) Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol 4:S49\u2013S55","journal-title":"Clin J Am Soc Nephrol"},{"key":"1377_CR27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000157629","volume":"29","author":"R Nishiura","year":"2009","unstructured":"Nishiura R, Fujimoto S, Sato Y et al (2009) Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients. Am J Nephrol 29:257\u2013263","journal-title":"Am J Nephrol"},{"key":"1377_CR28","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/hq1001.097102","volume":"21","author":"PA Price","year":"2001","unstructured":"Price PA, June HH, Buckley JR, Williamson MK (2001) Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 21:1610\u20131616","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1377-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-010-1377-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1377-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T04:14:36Z","timestamp":1591848876000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-010-1377-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,2]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["1377"],"URL":"https:\/\/doi.org\/10.1007\/s00198-010-1377-0","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,2]]}}}